Yao FY - Search Results

1

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.

Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR. Yao FY, et al. Liver Transpl Surg. 1999 Nov;5(6):491-6. doi: 10.1002/lt.500050605. Liver Transpl Surg. 1999. PMID: 10545536 Free article.

2

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection.

Yao FY, Bass NM. Yao FY, et al. J Hepatol. 2000 Aug;33(2):301-7. doi: 10.1016/s0168-8278(00)80371-2. J Hepatol. 2000. PMID: 10952248 Clinical Trial.

3

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Yao FY, et al. Hepatology. 2001 Jun;33(6):1394-403. doi: 10.1053/jhep.2001.24563. Hepatology. 2001. PMID: 11391528

4

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.

Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Yao FY, et al. Hepatology. 2001 Aug;34(2):411-6. doi: 10.1053/jhep.2001.26512. Hepatology. 2001. PMID: 11481627

5

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.

Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Yao FY, et al. Liver Transpl. 2002 Sep;8(9):765-74. doi: 10.1053/jlts.2002.34892. Liver Transpl. 2002. PMID: 12200775 Free article.

6

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Yao FY, et al. Liver Transpl. 2002 Oct;8(10):873-83. doi: 10.1053/jlts.2002.34923. Liver Transpl. 2002. PMID: 12360427 Free article.

7

Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.

Yao FY. Yao FY. J Clin Gastroenterol. 2003 May-Jun;36(5):440-2. doi: 10.1097/00004836-200305000-00017. J Clin Gastroenterol. 2003. PMID: 12702990

8

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.

Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. Yao FY, et al. Liver Transpl. 2003 Jul;9(7):684-92. doi: 10.1053/jlts.2003.50147. Liver Transpl. 2003. PMID: 12827553 Free article.

9

De novo non-alcoholic fatty liver disease following orthotopic liver transplantation.

Poordad F, Gish R, Wakil A, Garcia-Kennedy R, Martin P, Yao FY. Poordad F, et al. Among authors: yao fy. Am J Transplant. 2003 Nov;3(11):1413-7. doi: 10.1046/j.1600-6143.2003.00203.x. Am J Transplant. 2003. PMID: 14525603 Free article.

10

Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.

Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Yao FY, et al. Hepatology. 2004 Jan;39(1):230-8. doi: 10.1002/hep.20005. Hepatology. 2004. PMID: 14752842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters